The city is set to double its investment in New York’s growing
life sciences sector with a $1 billion cash injection to build new lab space,
spur research and create a pipeline of talent.
Mayor de Blasio and the New York City Economic Development Corporation (NYCEDC) announced today a plan double the City’s original $500 million investment in life sciences to $1 billion as part of LifeSci NYC, a commitment launched by the mayor to create jobs and establish New York City as the global leader in life sciences. de Blasio launched the LifeSci NYC initiative in 2016 with a visit to the Kallyope lab in the The Alexandria Center for Life Science
Choroid plexus tissue, anchored in each of the brain s ventricles and bathed in cerebrospinal fluid, is a small but influential player in the brain. It s now been spatially inventoried with single-cell RNA sequencing, cataloguing its cell types and gene expression patterns in each ventricle during early development, adulthood, and old age.
E-Mail
IMAGE: CRISPR-sciATAC is a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide. The new method harnesses the programmability of the gene editing system. view more
Credit: Sanjana Lab of New York Genome Center and NYU
NEW YORK, NY (April 29, 2021) - In a new resource for the scientific community, published today in
Nature Biotechnology, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) developed CRISPR-sciATAC, a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide. With this technology, they profile changes in genome organization and create a large-scale atlas of how loss of individual chromatin-altering enzymes impacts the human genome. The new method harnesses the programmability of the gene editing system CRISP
Stanley R Frankel, MD FACP joins Cytovia Therapeutics as Chief Medical Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Axion BioSystems Announces Formation of Scientific Advisory Board
April 20, 2021 GMT
ATLANTA (BUSINESS WIRE) Apr 20, 2021
Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells
in vitro, announces the formation of a Scientific Advisory Board (SAB). The SAB will be chaired by Jim Ross, Ph.D., founder and Chief Technology Officer, and will work closely with Axion BioSystems’ management team to help identify and prioritize Axion’s next generation of bioelectronic products.